Speciality Medicines IPO

Speciality Medicines is a BSE SME IPO listed on the BSE SME platform, priced at ₹117–₹124 per share. The stock debuted at ₹124 with a flat listing performance. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹2,48,000.

Speciality Medicines Limited IPO

BSE SME Listed
₹2,48,000 (2000 Shares)
Minimum Investment
Check Allotment
IPO Dates
Mar 20, 2026 – Mar 24, 2026
Price band
₹117-124 per equity share
Minimum Investment
₹2,48,000
Issue size
₹29.14 Cr
Lot size
1000
Allotment Date
Mar 25, 2026
Listing
Mar 30, 2026
Listing At
BSE SME

IPO timeline

  1. Mar 20, 2026

    Open Date

    Completed

  2. Mar 24, 2026

    Close Date

    Completed

  3. Mar 25, 2026

    Allotment Date

    Completed

  4. Mar 30, 2026

    Listing Date

    Completed

Speciality Medicines IPO Subscription Details

View Subscription Details
QIB 96.24x
Individual 0.85x
NIIs 2.01x
bHNI 2.70x
sHNI 0.64x
Individual 0.85x
Total 2.33x

Speciality Medicines IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.

Last updated:

Speciality Medicines IPO Essentials

Speciality Medicines IPO Details

Speciality Medicines IPO is priced at ₹117-124 per share with a total issue size of 29.14 crore. The IPO has a lot size of 1000 shares and is listed on a BSE SME.

Issue price
₹117-124 per equity share
Lot size
1000 shares
Face value
₹10 Per Equity Share
Issue size
23,50,000 shares(agg. up to ₹29.14 Cr)
Total issue size
23,50,000 shares
(aggregating up to ₹29.14 crore)
Fresh issue
23,50,000 shares
(aggregating up to ₹29.14 crore)
Listing at
BSE SME
List price
124.0
Listing date
Registrar
Skyline Financial Services Pvt.Ltd.
Lead manager
UNISTONE CAPITAL PRIVATE LIMITED

Market Lot Size

Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Individual (min) 2 2,000 ₹2,48,000
Individual(max) 2 2,000 ₹2,48,000
sHNI(min) 3 3,000 ₹3,72,000
sHNI(max) 8 8,000 ₹9,92,000
sHNI(min) 9 9,000 ₹11,16,000

Speciality Medicines IPO Documents

Speciality Medicines IPO Reservation

Speciality Medicines IPO reservation details show category-wise allocation of shares. Out of the total 2350000 shares, approximately 0.89% are reserved for QIB, 46.34% for NII, 46.38% for retail investors, and 6.38% for market maker.

Investor Category Shares Offered Maximum Allottees
Market Maker Shares Offered 150000 (6.38%)
QIB Shares Offered 21000 (0.89%)
NII (HNI) Shares Offered 1089000 (46.34%)
bHNI > ₹10L 726000 (19%) 242
sHNI < ₹10L 363000 (9%) 121
Individual Shares Offered 1090000 (46.38%) 545
Total Shares Offered 2350000 (100%)

Speciality Medicines IPO Analytics

Speciality Medicines IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

Speciality Medicines IPO Subscription Status

Speciality Medicines IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO is currently subscribed 2.33x, indicating moderate demand across investor categories.

As on QIB
NII
bHNI
sHNI
Individual Total
Shares Offered / Reserved 21,000
10,89,000
7,26,000
3,63,000
10,90,000 22,00,000
Day 1 20-03-26 05:00 PM
1.00 x
1.60x
2.37x
0.06x
0.07 x 0.84 x
Day 2 23-03-26 05:00 PM
1.00 x
1.82x
2.68x
0.10x
0.19 x 1.01 x
Day 3 24-03-26 05:00 PM
96.24 x
2.01x
2.70x
0.64x
0.85 x 2.33 x
Total No. of Applications
bHNI sHNI Individual
685 (Approx) 0.69x 0.45x 0.85x

Speciality Medicines Valuations

Earnings

EPS Pre IPO
₹13.38/-
EPS Post IPO
₹11.82/-
P/E Pre IPO
9.27
P/E Post IPO
10.49

Returns

ROE
37.85%
ROCE
33.39%
RoNW
28.30%
PAT Margin
14.77%

Fundamentals

Debt / Equity
0.17
Price / Book
2.62
Market Cap
108.94 Cr.

Data sourced from DRHP / RHP • For educational purposes only

Speciality Medicines Financials( In Crs.)

31-Oct-25 31-Mar-25 31-Mar-24
Assets 45.57 39.98 22.68
Revenue 36.93 58.54 27.66
Profit After Tax 6.06 8.61 2.93
Net Worth 36.47 30.42 15.06
Reserves & Surplus 30.04 23.98 9.95
Total Borrowing 4.81 5.05 2.86

Speciality Medicines Company & Offer Insights

About Speciality Medicines

Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue.

As of August 31, 2025, the company had a total of 18 permanent employees in various departments.

Speciality Medicines Promoter(s)

Parth B Goyani, Goyani Sumit Babubhai are the company's promoters of Speciality Medicines.

Speciality Medicines IPO Issue Objectives

Setting up of Research and Development (R&D) Center
Product registration in the international markets
Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company
To Meet Working Capital Requirements
General Corporate Purpose

Contact Information

Contact Details

Speciality Medicines

+91 22 4604 5344

investors.grievances@specialitymedicine.com

https://specialitymedicine.com

913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.

Registrar Contact Details

Skyline Financial Services Private Ltd

02228511022

ipo@skylinerta.com

https://www.skylinerta.com/ipo.php

Frequently Asked Questions

Click any question to reveal the answer

Speciality Medicines IPO is a book-built IPO worth ₹29.14 crore. The price band is ₹117–₹124 per share. The IPO opens on Mar 20, 2026 and closes on Mar 24, 2026. It will be listed on BSE SME Platform. Skyline Financial Services Pvt. Ltd. is the registrar.

The price band of Speciality Medicines IPO is ₹117 to ₹124 per share.

The lot size of Speciality Medicines IPO is 1000 shares.

The minimum investment for Speciality Medicines IPO is approximately ₹2,48,000 based on the upper price band .

Speciality Medicines IPO opens on Mar 20, 2026 and closes on Mar 24, 2026.

The allotment date of Speciality Medicines IPO is Mar 25, 2026.

Speciality Medicines IPO is expected to be listed on Mar 30, 2026, on BSE SME Platform.

Speciality Medicines IPO valuation snapshot: P/E 10.49, EPS ₹11.82/-, P/B 2.62, RoNW 28.30%, and market cap 108.94 Cr.

To apply for Speciality Medicines IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of Speciality Medicines IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for Speciality Medicines IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check Speciality Medicines IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Speciality Medicines IPO allotment status on IPO Ji for quick and easy access.